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Objective: Inflammation and elastinolysis are observed in the media of abdominal aortic aneurysms (AAAs) where vascular
smooth muscle cell (VSMC) density is decreased. In contrast, elastin and VSMCs are preserved in the noninflammatory
media of stenotic atherosclerotic lesions. We have tested the hypothesis that VSMCs exert a protective effect against
inflammation and proteolysis in a model of AAA in rats, in which medial elastin degradation is driven by inflammation
and matrix metalloproteinases.
Method: Decellularized guinea pig aortas (xenografts) were implanted orthotopically into Fischer-344 rats and seeded
with a suspension of rat VSMCs syngeneic to the rat recipient, or were infused with culture medium as a control. Diameter
and elastin in the media were quantified 8 weeks after implantation. Inflammation, matrix metalloproteinase (MMP) and
tissue inhibitor of matrix metalloproteinase (TIMP) expression were analyzed 1 and 2 weeks after implantation.
Results: VSMC addition prevented AAA formation (mean  standard deviation diameter increase: 198.2%  106.6% vs
35.3%  17.8%, P  .009), elastin degradation, and decreased infiltration by monocyte-macrophages. Reverse-
transcriptase polymerase chain reaction, zymography and reverse zymography for MMP-2, MMP-9, TIMP-1, TIMP-2,
and TIMP-3 demonstrated a shift of the proteolytic–antiproteolytic balance upon addition of VSMCs. Transcriptional
changes were observed in the adventitia, although seeded VSMCs remained located in the intima.
Conclusions: VSMCs exert a paracrine effect on the adventitia that participate in artery wall homeostasis against
inflammation and proteolysis. Failure of this protective mechanism results in AAA formation. The understanding of the
molecular mechanisms underlying VSMC protective effect may represent a new approach in the treatment of aneurysm
and plaque rupture. (J Vasc Surg 2002;36:1018-26.)
Abdominal aortic aneurysms (AAAs) form as a result of
extracellular matrix (ECM) destruction.1-3 In contrast to
stenotic atherosclerotic lesions where artery wall changes
are localized predominantly in the intima and adventitia,
changes in AAAs extend to the media layer where increased
inflammation and elastin destruction are observed. Deter-
minants of the medial tropism in the aneurysmal disease are
unknown. Vascular smooth muscle cells (VSMCs), the
specific cellular component of the media in normal arteries,
are in decreased number in AAAs, in contrast to aortoiliac
stenotic lesions.4,5 A loss of medial VSMCs is also observed
in animal models of aneurysms.1,6-11 The actual contribu-
tion of VSMC loss in the initiation of AAA formation, and
its possible role in the spreading of inflammation to the
media, are unclear. Studies of human AAAs have provided
contradictory information. On the one hand, remaining
VSMCs in the media have been shown to produce matrix
metalloproteinase-9 (MMP-9),12,13 suggesting that
VSMCs may participate in ECM destruction. On the other
hand, VSMCs may produce collagen type I, and, therefore,
participate in wall reconstruction and AAA stabilization.14
However, human AAAs harvested during elective surgery
are advanced lesions. Molecular and cellular mechanisms
observed at this delay may not reflect the mechanisms
involved in aneurysm formation. Moreover, none of these
studies were designed to test the contribution of VSMC
loss in AAA formation. VSMC disappearance in the media
layer could be a step necessary to the spreading of inflam-
mation to the media and to ECM destruction, or it could be
merely a consequence of ECM destruction. In the present
work, we have tested the hypothesis that the presence or
absence of VSMCs modulates ECM destruction by pro-
teases and the spreading of inflammation to the media, and,
therefore, determines early events in the formation of an-
eurysms.
We have developed a model of aneurysm by using
decellularized guinea pig aortas (xenografts) implanted in
rats.15 Macrophages and T and B lymphocytes infiltrate the
adventitia of the xenograft in a ratio similar to that of
human AAAs.16 Later on, inflammation spreads to the
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media where elastin is degraded and is replaced by a colla-
gen-rich wall with fibroblasts as aneurysm develops.10,11
MMPs and plasminogen activators are up-regulated during
the process, as observed in human AAAs, and their inhibi-
tion by overexpression of tissue inhibitor of matrix metal-
loprotease-1 (TIMP-1), or plasminogen activator inhibi-
tor-1, prevent xenograft aneurysmal degeneration.17,18
Because the xenograft is decellularized before implanta-
tion, it contains no VSMC of guinea pig or rat origin, and
thereby models aortic ECM exposure to inflammation and
proteolysis in the absence of VSMCs. VSMCs that are
syngeneic to the rat recipient can be seeded onto the
xenograft lumen, where they accumulate and form an inti-
mal layer.17 In this way the impact of VSMCs on aneurys-
mal degeneration can be tested.
We show that VSMC seeding prevents aneurysm for-
mation by decreasing inflammation spreading to the media,
and by shifting towards inhibition the MMP-dependent
proteolytic balance in the adventitia, in a paracrine manner.
Our data suggest that failure of VSMCs in maintaining
artery wall homeostasis against inflammation, is a step
necessary to arterial aneurysm formation.
MATERIAL AND METHODS
Animals and surgery. Male Fischer-344 rats (Iffa
Credo, Lyon, France) and male Hartley guinea pigs (Saint
Antoine, France) were housed and cared for according to
the European Union Standards. The protocol was ap-
proved by the animal experiments ethics committee at our
institution. Animals were anesthetized with 5 mg/100 g
body weight intraperitoneal pentobarbital. Guinea pig ab-
dominal aortas decellularized with 0.1% sodium dodecyl-
sulfate (Sigma Chemical, St Louis, Mo) were implanted
orthotopically in rats.15
Graft diameter and length were measured immediately
after transplantation (T) and before euthanasia (E). In-
crease from value at transplantation was calculated as fol-
lows: (E  T)  100/T (%). The graft was defined as
aneurysmal if the diameter increase was 50%.19
Endoluminal seeding of VSMCs. Male Fischer-344
rat VSMCs isolated from thoracic aortas20 were grown to
confluency in Roswell Park Memorial Institute (RPMI)
1640 and Medium 199, with L-glutamine, 10% fetal calf
serum, penicillin-streptomycin, and fungizone (Gibco-
BRL, Gaithersburg, Md).
Passage five to eight VSMCs were resuspended in
M199 culture medium with 5% fetal calf serum and injected
into the graft lumen (107 cells per graft) immediately after
transplantation. Two weeks after seeding, PKH26-labeled
VSMCs labeled with the fluorescent dye PKH26 (Sigma)
were observed only in the intima of the grafts. As a control,
grafts were infused with M199 culture medium with 5%
fetal calf serum.
Histology and immunochemistry. Cryostat cross-
sections (5 m) were fixed in cold methanol. Computer-
ized quantification of elastin in the media was done after
orcein staining, by using a video microscope and the Perfect
Image Master image analysis software (Clara Vision, Mont-
rouge, France). Results were the mean of regularly spaced
measurements in the media. For immunohistochemistry,
primary antibodies were mouse anti-rat monoclonals: ED1
clone for monocytes and macrophages, RLN-9D3 for B
cells, R73 for TCR / receptor of T lymphocytes, rat
endothelial cell antigen for endothelial cells (Medgene
Science, Pantin, France), and 1A4 for alpha-actin (Dako-
patts, Copenhagen, Denmark). An alkaline phosphatase-
anti alkaline phosphatase technique was used (Dakopatts).
Control sections were treated in the same way, except that
the primary antibody was omitted, or a nonrelevant primary
antibody was used. Labeled cells were counted with use of
a grid in the microscope eyepiece. For each graft, results
were the mean of regularly spaced counts.
Analysis of MMP and TIMP mRNA contents.
MMPs and TIMP mRNA levels were compared between
groups by using reverse-transcriptase polymerase chain re-
action (RT-PCR), comparative to the domestic gene 18s
(QuantumRNA 18s Internal Standards kit, Ambion, Mon-
trouge, France). Intima and media plus adventitia were
separated by microdissection, and pooled by group. Total
RNA was extracted with TRIzol (Life Technologies, Grand
Islands, NY) and treated with grade I DNAse (Roche
Molecular Biomedicals, Manneheim, Germany). Reverse
transcription was done with 1 g of extracted RNA, 60 ng
of random primers, 200 U Superscript II (Life Technolo-
gies), 0.2 mmol dNTP, in 10 mmol dithiothreitol and 20 U
ribonuclease inhibitor (Roche Molecular Biochemicals).
PCR was performed in a PCR Express thermocycler (Hy-
baid, Ashford, UK), in the same tube for both the gene of
interest and 18s. Final PCR conditions were chosen to
avoid interference between the two sets of primers. Primers
for genes of interests are listed in the table (Genset Oligos
SA, Paris, France). The mix contained 2.5 U of Taq Poly-
merase (EurobioTaq, Eurobio, Les Ulis, France) in PCR
buffer, 200 mol of dNTP, and magnesium chloride. Neg-
Primer sequences for polymerase chain reaction
Gene Forward Reverse Base pairs
MMP-2 5-CTATTCTGTCAGCACTTTGG-3/ 5-CAGACTTTGGTTCTCCAACTT-3 309
MMP-9 5-CTGCGTATTTCCATTCATCTT-3/ 5-ATGCCTTTTATGTCGTCTTCA-3* 456
TIMP-1 5-CCCCAGAAATCAACGAGACCA-3/ 5-ACACCCCACAGCCAGCACTAT-3 303
TIMP-2 5-GCAGAAGGAGATGGCAAGATG-3/ 5-CGGGGAGGAGATGTAGCAAGG-3 162
TIMP-3 5-GTGGTGGGAAAGAAGCTGCTGAA-3/ 5-CCTCGGTACCAGCTGCAGTAGC-3* 454
*Sequencing of PCR products showed total homology with published rat sequences.
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ative controls were realized with the same protocol, but
without Superscript II. Ten L of the PCR products were
run in a 2% agarose gel with 5 g/mL ethidium bromide,
were visualized under ultraviolet light, and photographed
with a video camera. Bands of amplified sequences of the
gene of interest and of 18s and were quantified with Gel
Analyst (Iconix, Montrouge, France). Results were ex-
pressed as a ratio between signals corresponding to the
gene of interest and 18s.
Analysis of MMP and TIMP activities. Intima and
media plus adventitia from six grafts harvested at 1 and 2
weeks were separated, and pooled by group and layer. After
extraction with a guanidine buffer,17 MMP-2 and MMP-9
activities were analyzed on 1% gelatin zymograms. MMP-2
and MMP-9-related bands were quantified with the Image-
Master software (Pharmacia Biotech, Uppsala, Sweden).
Results were plotted against a standard curve generated on
the same gel with purified human recombinant MMP-2 or
MMP-9 (Medgene Science, Pantin, France). In order to
quantify MMP-9 complexed with TIMP molecules, in
some experiments, TIMPs were inactivated by reduction-
alkylation.17
TIMP activities were detected with a Reverse Zymog-
raphy Kit (University Technologies Intl. Inc, Calgary, Al-
berta, Canada).
Statistical analysis. Results were expressed as mean	
standard deviation. Comparisons between two groups were
done by using the nonparametric Mann-Whitney U test.
P 
 .05 was accepted as statistically significant.
RESULTS
VSMCs prevent AAA formation and preserve elas-
tin. The seeding of VSMCs prevented aneurysmal degen-
eration and length increase. Mean diameter increase at 8
weeks was 198.2 	 106.6% (n  6) without seeding, and
35.3 	 17.8% (n  6) after seeding (P  .009)(Fig 1).
Loss of elastin in the media layer is a hallmark of
aneurysms.1,2,6-8,10,11 In absence of VSMCs, elastin in the
media was deleted at 8 weeks (17.2 	 3.8 surface-%),
whereas addition of VSMCs preserved elastin (38.3 	 3.3
surface-%, P  .014) (Fig 2).
MVSMCs modulate artery wall inflammation. We
have previously identified two phases of inflammation in
the xenograft model10: the recruitment of inflammatory
cells in the intima and adventitia during the first week, and
the spreading of inflammation to the media.
The first, intimal, and adventitial phases were not af-
fected by VSMC seeding (data not shown). As for the
second phase, VSMCs decreased infiltration of the media
by monocyte-macrophages at 2 weeks (0.25	 0.07 ED1
cells/104 mm2 with no VSMCs, and 0.07	 0.02 ED1
cells/104 mm2 after seeding (P  0.014)) (Fig 3). Infil-
tration by T and B lymphocytes was not affected by VSMCs
(data not shown).
Because recruitment of inflammatory cells in aneurysms
could be mediated in part by neovessels, we asked whether
VSMCs had modified neovessel accumulation in the adven-
titia. At 2 weeks, VSMC seeding resulted in an increase in
cells detected by immunostaining by RECA-antibody,
without reaching statistical significance (0.023 	 0.003 vs
0.026 	 0.003 RECA cells/104 mm2, P  .076).
Effect of VSMCs on MMP-dependent proteolytic
balance. We have shown previously that prevention of
xenograft aneurysmal degeneration by TIMP-1 or plasmin-
ogen activator inhibitor-1 overexpression is paralleled by a
Fig 1. Vessel diameter and length. VSMC seeding (VSMC )
prevented xenograft diameter and length increase. Increases were
determined in reference to values immediately after transplanta-
tion.
Fig 2. Quantification of elastin in the media. VSMC seeding
(VSMC ) preserved elastin in the media. Elastin in xenograft
media was measured by computerized morphometric analysis on
cross-sections. S%: surface-% of area stained by elastin-specific dye
orcein. White bar, 1 week; hatched bar, 2 weeks; black bar, 8 weeks.
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decrease in MMP-9 activity.17,18 We have analyzed the
expression of two gelatinases and elastases21; constitutive
MMP-2 and inducible MMP-9; and of TIMP-1, 2, and 3.
Because at 1 week, inflammation is limited to the adventi-
tia, extracted mRNAs at this delay reflect transcription in
the adventitia.
MMP-2 expression. VSMC seeding resulted in an
increase in MMP-2 mRNA and activity in the intima, and a
decrease in the media and adventitia (Fig 4).
MMP-9 expression. On the basis of mRNA levels
analysis, MMP-9 appeared to be synthesized mostly in the
media and adventitia. VSMCs induced a strong decrease in
mRNA at 1 week, and, therefore, in the adventitia of the
vessels where inflammatory cells were accumulated at this
time-point. The bulk of MMP-9 activity, however, was
concentrated in the intima (Fig 5).
Effect of VSMCs on TIMP expression. MMP activ-
ity is modulated by TIMPs, which form inhibitory com-
plexes with the enzyme. TIMP mRNAs were low in the
nonseeded vessels, except for TIMP-3 in the media and
adventitia. VSMC seeding increased TIMP-1, 2, and 3
mRNAs in all layers (Fig 6). At 1 week during the recruit-
ment phase of inflammatory cells in the adventitia, TIMP-3
activity was increased in the media and adventitia of non-
seeded vessels. Because no inflammatory cells had pene-
trated into the media at this time-point, this result reflects
activity in the adventitia. At 2 weeks, after penetration of
inflammatory cells into the media, and during ECM degra-
dation in the media of nonseeded vessels, TIMP-3, and to
a lesser extend TIMP-2, activities were sharply increased in
the VSMC-seeded group (Fig 7).
Because the decrease in MMP-9 activity after seeding
could be caused by inhibitory complex formation with
TIMP, we quantified the gelatinase after neutralization of
TIMPs. Reduction-alkylation did not result in a significant
increase in MMP-9 activity in seeded xenografts (data not
shown), suggesting that VSMCs decreased MMP-9 at a
transcriptional level.
DISCUSSION
In quiescent adult arteries, VSMCs are located mostly
in the media layer where they exhibit low metabolic, syn-
thetic, and proliferative activities.22 Their principal func-
tion is the modulation of vascular tone, mostly in small-
caliber arteries. In pathologic conditions, VSMCs
participate in the vessel-wall response to stimuli such as
atherosclerosis and injury, and in vessel healing or stenotic
disease.23-26 In a previous study, we have shown that the
seeding of VSMCs transduced by a retroviral vector with no
gene of interest prevents the aneurysmal degeneration of
xenografts.17 This first result, although obtained with a
clone of genetically modified cells, has prompted us to
study the possible role of VSMCs in protecting arterial
ECM. In the present work, we demonstrate that VSMCs
exert a protective effect on artery wall ECM against inflam-
Fig 3. Impact of VSMCs on inflammation in the media. Immunohistochemistry with monoclonal antibodies for
VSMCs (anti--actin) and monocyte-macrophages (ED1 clone). VSMC accumulation in the intima after seeding
resulted in decreased infiltration of the media by monocyte-macrophages. Black arrows point to internal elastic laminae.
T, Luminal thrombus.
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mation and proteolysis, and that the absence of VSMCs
promotes aneurysm formation.
Previous studies have demonstrated that VSMCs in
AAA express MMP-9.12,13 Moreover, when in contact with
T lymphocytes through CD40-CD40-ligand,27 or upon
cytokine stimulation,28 VSMCs in vitro can express
MMP-9. These results support the view that VSMCs may
participate in ECM destruction and aneurysm formation.
However, because human samples can be studied only after
the lesion has formed, the observed MMP expression and
VSMC death may reflect consequences of VSMC exposure
to inflammation, rather than an actual participation of
VSMCs in the initiation of aneurysmal degeneration. Xeno-
grafts are decellularized before implantation and are, there-
fore, depleted of VSMCs.15 The addition of rat syngeneic
VSMCs immediately after engraftment allowed us to define
a role for VSMCs in the initiation of AAA degeneration. We
have studied xenografts at early time-points, when the
seeding of VSMCs had not resulted in additional ECM
formation to strengthen the vessel wall mechanically. In
fact, we had shown previously that VSMCs are not neces-
sary to maintain the diameter of isografts, which are not
subjected to inflammation and proteolysis.15 Overall, the
present experiments demonstrate that one main early im-
pact of VSMCs in arteries subjected to inflammation is the
modulation of inflammation spreading and proteolysis.
Inflammation in the media is a hallmark of human and
experimental AAAs.10,16,29 The important role played by
inflammation in AAAs is suggested by the fact that inhibi-
tion of inflammatory cell adhesion by anti-CD18 antibody
prevents experimental aneurysmal degeneration,30 and that
nonsteroidal antiinflammatory drugs slow human AAA de-
velopment.31,31 Inflammatory cells appear to be a promi-
nent source of proteases responsible for ECM destruction,
and of cytokines responsible for VSMC death, both in the
media in AAAs and also in the intima in ruptured plaques.
VSMC depletion and inflammation are co-local-
ized,32-34 possibly because inflammation can cause VSMC
death.4,5,31,35,36 We demonstrate that the absence of
VSMCs increases mononuclear phagocyte spreading to the
media, without affecting accumulation of inflammatory
cells in the adventitia or angiogenesis. Hence, whereas
inflammation causes VSMC death, we show that absence of
VSMCs exacerbates inflammation in our model. Taken
Fig 4. VSMCs and MMP-2 expression. Tissue extraction was done after microsurgical separation of the intima from
the media and adventitia. MMP-2 mRNA levels were determined by semi- quantitative RT-PCR, and expressed as
ratios to 18s mRNA. The experiment was repeated with similar results on different batches consisting of pools of four
to five grafts, after intima and media plus adventitia separation. MMP-2 activity was measured on gelatin zymograms.
VSMC seeding resulted in an increase in constitutive MMP-2 mRNA and activity in the intima at 1 week for activity.
Data represent the mean 	 SD of four different gels of the same pool of four to five grafts. At 2 weeks, activity was
decreased in the media and adventitia after VSMC seeding. ma, Media plus adventitia; rMMP-2, recombinant
MMP-2.
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together, data from the literature and our data suggest a
scenario in which inflammation induces VSMC death,
which in turn allows up-regulation of protease expression
and the spread of inflammation.
Both penetration of inflammatory cells and destruction
of ECM in the media require proteolysis. We have demon-
strated previously the role of MMPs in xenograft degener-
ation at the end of a complex cascade of events.17 Our
Fig 5. VSMCs decrease MMP-9 expression. MMP-9 activity was localized mainly in the intimal thrombus of
nonseeded xenografts, whereas synthesis was localized in the media and adventitia, as shown by mRNA content. VSMC
seeding resulted in a sharp decrease in MMP-9 expression, at activity and mRNA levels, in the intima and in the media
and adventitia, respectively. These results suggest that intimal VSMCs exert a paracrine effect on the surrounding layers
that decrease gene expression. ma, Media plus adventitia; rMMP-9, recombinant MMP-9.
Fig 6. VSMCs increase TIMP-1, 2, and 3 mRNA. Increase in mRNA upon VSMC seeding was observed for the three
TIMPs. VSMCs appeared to be a major source of TIMP. However, TIMP mRNAs were induced in the media and
adventitia, suggesting a paracrine effect of intimal VSMCs. mRNA contents are expressed as ratios to 18s mRNA. ma,
Media plus adventitia.
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results provide evidence that VSMCs control the medial
aspect of inflammation spreading by shifting the MMP-
dependent proteolytic balance toward inhibition. VSMCs
both decrease expression of the gelatinolytic and elastino-
lytic MMP-9, and increase TIMP expression, at transcrip-
tional and activity levels. Reduction–alkylation experiments
show that the participation of TIMPs in decreasing MMP-9
activity is marginal, and that most of the effect is a transcrip-
tional down-regulation of MMP-9. One week after seed-
ing, the intima is mostly composed of VSMCs and contains
large amounts of TIMP-1, 2, and 3, as well as constitutive
MMP-2 and low levels of MMP-9. This pattern is similar to
that of quiescent human and rat VSMCs in culture, and in
the VSMC-rich media around atherosclerotic lesions,
which express MMP-2 and TIMP-1 and 2. In human
atherosclerotic stenotic lesions, in situ zymography fails to
detect gelatinolytic activities in VSMC-rich areas.37 In this
respect, VSMCs after seeding in the intima in our model
resemble VSMCs in the media of normal aorta. On the basis
of these results, we propose that in atherosclerotic, but
nonaneurysmal aortas, as well as in seeded xenografts,
VSMCs maintain the proteolytic burden at a low level.
Conversely, when VSMCs are in decreased number or
absent, ie, in human AAAs or in nonseeded xenografts,
proteolysis is up-regulated.
In a report of a study of small-diameter human AAAs,
ECM degradation in the adventitia was noted to be an early
event in the aneurysmal disease.38 AAA development may
require a higher level of activation of adventitial inflamma-
tory cells before invasion occurs in the medial layer. Our
results show that VSMCs modify the MMP-dependant
balance in the adventitia at the level of mRNA. It is note-
worthy that we did not detect any difference in the number
of adventitial inflammatory cells at this time-point. There-
fore, a decrease in MMP-9 content occurs because VSMCs
affect gene expression in adventitial inflammatory cells,
preventing them from turning into a proteolytic phenotype
and, therefore, preventing the spread of inflammation from
the adventitia to the media.
The mechanism by which intimal VSMCs modulate
gene expression in the adventitia remains to be determined.
VSMC density could alter diffusion of blood-circulating
cytokines or proteases through the aortic wall and thereby
affect adventitial inflammatory cell phenotype. The present
experiment models in vivo cross-talks between VSMCs and
inflammatory cells, with no direct cell-to-cell contact.
Modifications in the surrounding inflammatory layers
could be mediated by soluble factors secreted by VSMCs, in
a paracrine manner. Interleukin (IL)-10 is expressed by
VSMCs in atherosclerotic lesions and is a potent inhibitor
of MMP-9 expression and inducer of TIMP-1 in mono-
cytes and macrophages.39,40 Identification of soluble fac-
tors potentially involved is under investigation in our labo-
ratory.
One potential limitation to our study is that VSMCs
harvested from aortic media, were seeded onto, and re-
mained in the intima of the xenograft, not in the media.
This intimal location may have altered the function of
seeded VSMCs. However, in the presence of inflammation,
depletion of VSMCs and up-regulation of MMP-9 produc-
tion by VSMCs41 can be observed similarly in the media in
AAAs and in the intima in ruptured atherosclerotic fibrous
caps.32-34,42 Therefore, cross-talks between VSMCs and
inflammatory cells are likely to take place in the media or in
the intima. In our model as in normal aortas, VSMCs are
located between lumen and adventitia, so that any factor
synthesized by VSMCs can diffuse radially to exert a para-
crine effect in the adventitia.
On the basis of these findings, our hypothesis is that,
when present, VSMCs limit proteolysis by modulating
inflammatory cell phenotype in the adventitia. As long as
this protective mechanism is maintained, inflammation re-
mains confined to the adventitia. The capacity of VSMCs to
contain inflammation is likely to be quantitatively limited,
as with any biologic process, such as the capability to
control the MMP-dependent proteolytic balance.17 If the
VSMC protective effect is turned off by death or by func-
tional alteration, or is overwhelmed by over-activation of
inflammation,17 adventitial proteolysis is turned on, in-
flammation spreads to the media, ECM is degraded in both
layers, and aneurysm forms. At a late stage of disease
progression, ie, in AAAs collected during surgery in hu-
Fig 7. VSMCs and TIMP activity. Reverse zymogram showing TIMP activity (dark bands) in the media and adventitia
of pools of five vessels. At 1 week after implantation, during the recruitment phase of inflammatory cells in the
adventitia, TIMP-3 was detected in nonseeded grafts. At 2 weeks, when the destructive infiltration of the media by
inflammatory cells had started, TIMP-3 was detected mostly in the seeded vessels.
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mans, remaining VSMCs may express proteases and partic-
ipate in ECM destruction.12,13 The production of MMP-9
by remaining VSMCs is not in contradiction with our
results. At this late phase of disease, VSMCs may no longer
be able to control adventitial inflammation, because their
number is decreased by apoptosis and because their pheno-
type has been modified by exposure to inflammatory cyto-
kines or by cell–cell contact through the CD40-CD40
ligand pathway.
In conclusion, the demonstration that VSMCs exert a
paracrine, protective effect against artery wall destruction
by inflammation points to a possible role of VSMCs in
maintaining artery wall homeostasis. Our results suggest
new therapeutic approaches to the prevention of athero-
sclerotic complications, based on the preservation or the
expansion of VSMCs in the artery wall.
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